Allianz Asset Management’s Integra LifeSciences IART Stock Holding History
Bought
Maintained
Sold
Other funds holding IART
RCMNY
PCMI
Allianz Asset Management's IART Position: Q2 2026 in Review
Allianz Asset Management increased its Integra LifeSciences (IART) stake by 13% in Q2 2026, buying an estimated $1.62M and bringing the position to 1,005,203 shares worth $18.1M. The position accounts for 0.02% of the portfolio, ranked #775.
Allianz Asset Management first reported a position in IART in Q3 2016 and has held it in 16 quarters since. 212 funds tracked by Wall St. Rank hold IART as of Q2 2026.
- Allianz Asset Management held 1,005,203 shares of Integra LifeSciences worth $18.1M as of Q2 2026.
- Allianz Asset Management bought 115,599 Integra LifeSciences shares in Q2 2026, an estimated $1.62M.
- Integra LifeSciences made up 0.02% of Allianz Asset Management's portfolio in Q2 2026, its #775 holding.
- Allianz Asset Management first reported a position in Integra LifeSciences in Q3 2016 and has held it in 16 quarters since.
- 212 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2026.
Based on Allianz Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.